CD55 and breast carcinoma: Mechanistically, authors showed that O-linked desialylation of CD55 by ST3GAL1 silencing results in increased C3 deposition and complement-mediated lysis of breast cancer cells, enhancing sensitivity to antibody-dependent cell-mediated cytotoxicity [92].